Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medicine and Health Sciences (34)
- Medical Sciences (31)
- Public Health (30)
- Medical Education (29)
- Medical Specialties (29)
-
- Education (28)
- Health Services Research (28)
- Health and Medical Administration (27)
- Primary Care (26)
- Health and Physical Education (25)
- Higher Education (24)
- Scholarship of Teaching and Learning (24)
- Teacher Education and Professional Development (24)
- Nursing (22)
- Life Sciences (4)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Biostatistics (2)
- Diseases (2)
- Pediatrics (2)
- Pharmacology (2)
- Pharmacology, Toxicology and Environmental Health (2)
- Statistical Methodology (2)
- Women's Health (2)
- Accounting (1)
- Alternative and Complementary Medicine (1)
- Anatomy (1)
- Animal Experimentation and Research (1)
- Institution
- Keyword
-
- Clinical trial (4)
- COVID-19 (3)
- Bayes’s rule (2)
- Clinical trials (2)
- Public health (2)
-
- Quantitative reasoning (2)
- Actemra (1)
- Alzheimer’s disease (1)
- Animal models (1)
- Apabetalone (1)
- BET inhibitor (1)
- Cardiovascular risk in ophthalmologists (1)
- Clinical care (1)
- Confidence interval (1)
- Coronavirus (1)
- Cure rate (1)
- Cytokine storm syndrome (1)
- Delayed treatment effect (1)
- Epigenetics (1)
- GMANOVA (1)
- Health research (1)
- Heteroscedasticity (1)
- Hypothesis testing (1)
- Mindfulness (1)
- Montreal cognitive assessment (1)
- Natural products (1)
- Non-proportional hazards (1)
- Nonnormality (1)
- Nonparametric Analysis (1)
- Obesity (1)
- Publication
- Publication Type
- File Type
Articles 31 - 43 of 43
Full-Text Articles in Clinical Trials
C10: Oral Potentially Malignant Disorders Prevalence In The Orthodontic Clinic, Mark Greene
C10: Oral Potentially Malignant Disorders Prevalence In The Orthodontic Clinic, Mark Greene
Annual Research Symposium
No abstract provided.
C8: Intravenous (Iv) Bolus Versus Iv Infusion As Initial Approach For Blood Pressure (Bp) In Acute Ischemic Stroke (Ais) Patients Receiving Tissue-Plasminogen Activator (Tpa), Alexander D. Bonca, Alana Whittaker
C8: Intravenous (Iv) Bolus Versus Iv Infusion As Initial Approach For Blood Pressure (Bp) In Acute Ischemic Stroke (Ais) Patients Receiving Tissue-Plasminogen Activator (Tpa), Alexander D. Bonca, Alana Whittaker
Annual Research Symposium
No abstract provided.
C4: Comparing The Sub-Gingival Levels Of Cytomegalovirus, Epstein-Barr Virus, Porphyromonas Gingivalis In Human Immunodeficiency Virus-1 Seropositive Patients With And Without Antiretroviral Therapy, Supriya Kheur
Annual Research Symposium
No abstract provided.
S3: Post-Covid-19 Recovery Care Plan For Older Adults With Continuing Symptoms Of Breathlessness And Fatigue, Nancy M. Bryan, Marie Wright-Rolf Edd, Msn, Rn, Siboney Zelaya Ph.D., Mph, Msn Ed, Rn, Justin Carbonel
S3: Post-Covid-19 Recovery Care Plan For Older Adults With Continuing Symptoms Of Breathlessness And Fatigue, Nancy M. Bryan, Marie Wright-Rolf Edd, Msn, Rn, Siboney Zelaya Ph.D., Mph, Msn Ed, Rn, Justin Carbonel
Annual Research Symposium
Background:
The CDC research actively continues gathering information related to short and long-term symptoms that remain following the acute phase of Covid-19 diagnosis (CDC, 2020).
Fatigue and shortness of breath are listed among the most commonly reported long-term symptoms of Covid-19:
- Fatigue
- Shortness of Breath
- Cough
- Joint Pain
- Chest Pain (CDC, 2020).
Evidence suggests that older adults over the age of 60 who have multiple comorbidities are more susceptible and are at a higher risk of contracting the Covid-19 virus thus potentially prolonging recovery time post diagnosis (Greenhalgh, Knight, A’Court, Buxton, & Husain, 2020).
The Agency for Healthcare Research and …
P14: Emerging Role Of Pharmacists In Treatment And Vaccination For Covid-19, Dwaynie Bacon Jr, Man Ha, Dr. Mandal
P14: Emerging Role Of Pharmacists In Treatment And Vaccination For Covid-19, Dwaynie Bacon Jr, Man Ha, Dr. Mandal
Annual Research Symposium
No abstract provided.
P5: Covid-19 Vaccine: Technology Platform, Efficacy And Immune Protection, Manas Mandal
P5: Covid-19 Vaccine: Technology Platform, Efficacy And Immune Protection, Manas Mandal
Annual Research Symposium
Roseman Research Day Symposium.
P2: Characteristics Of Individuals With Oral Hpv Positive Results, Val Cheever, Eric Hon, Andrew J. Gross, Man Hung
P2: Characteristics Of Individuals With Oral Hpv Positive Results, Val Cheever, Eric Hon, Andrew J. Gross, Man Hung
Annual Research Symposium
No abstract provided.
O2: In-Silico Approach To Analyze Anticancer Activity Of Withania Somnifera In Oral Cancer, Gauri Kumbhar
O2: In-Silico Approach To Analyze Anticancer Activity Of Withania Somnifera In Oral Cancer, Gauri Kumbhar
Annual Research Symposium
No abstract provided.
Resident Heart Rate Variability During Cataract Surgery, Ahmad Baiyasi, Shibandri Das, Ferris Bayasi, Faisal Ridha Al-Timimi
Resident Heart Rate Variability During Cataract Surgery, Ahmad Baiyasi, Shibandri Das, Ferris Bayasi, Faisal Ridha Al-Timimi
Medical Student Research Symposium
Purpose: To evaluate ophthalmology resident anxiousness and cardiovascular response by tracking resident heart rate (HR) when performing cataract surgery during their last year of residency.
Methods: A prospective analysis of 31 cataract cases, completed by three residents (two females and one male), at the Kresge Eye Institute in August and September 2020 was performed. Inclusion criteria for cases included all cataract cases performed by PGY-4 residents at the Kresge Eye Institute who downloaded the Heart Graph app supported by iOS. Residents with android mobile devices were excluded from the study. Informed consent was obtained from all residents who utilized the …
Optimal Two-Stage Designs Based On Restricted Mean Survival Time For A Single-Arm Study, Guogen Shan
Optimal Two-Stage Designs Based On Restricted Mean Survival Time For A Single-Arm Study, Guogen Shan
School of Public Health Faculty Research
© 2021 The Author(s) Restricted mean survival time is an alternative measure of treatment effect to hazard ratio in clinical trials with time-to-event outcome. The current methods have been focused on one-stage designs. In this article, we propose optimal two-stage designs for a single-arm study with the smallest expected sample size. We compare the performance of the new optimal two-stage designs with the existing one-stage design with regards to the expected sample size and the expected total study length. The simulation results indicate that the new two-stage designs can save the expected sample size substantially as compared to the one-stage …
Using Covid-19 Vaccine Efficacy Data To Teach One-Sample Hypothesis Testing, Frank Wang
Using Covid-19 Vaccine Efficacy Data To Teach One-Sample Hypothesis Testing, Frank Wang
Numeracy
In late November 2020, there was a flurry of media coverage of two companies’ claims of 95% efficacy rates of newly developed COVID-19 vaccines, but information about the confidence interval was not reported. This paper presents a way of teaching the concept of hypothesis testing and the construction of confidence intervals using numbers announced by the drug makers Pfizer and Moderna publicized by the media. Instead of a two-sample test or more complicated statistical models, we use the elementary one-proportion z-test to analyze the data. The method is designed to be accessible for students who have only taken a …
Novel Nonparametric Testing Approaches For Multivariate Growth Curve Data: Finite-Sample, Resampling And Rank-Based Methods, Ting Zeng
Theses and Dissertations--Statistics
Multivariate growth curve data naturally arise in various fields, for example, biomedical science, public health, agriculture, social science and so on. For data of this type, the classical approach is to conduct multivariate analysis of variance (MANOVA) based on Wilks' Lambda and other multivariate statistics, which require the assumptions of multivariate normality and homogeneity of within-cell covariance matrices. However, data being analyzed nowadays show marked departure from multivariate normal distribution and homoscedasticity. In this dissertation, we investigate nonparametric testing approaches for multivariate growth curve data from three aspects, i.e., finite-sample, resampling and rank-based methods.
The first project proposes an approximate …
Innovative Statistical Models In Cancer Immunotherapy Trial Design, Jing Wei
Innovative Statistical Models In Cancer Immunotherapy Trial Design, Jing Wei
Theses and Dissertations--Statistics
A challenge arising in cancer immunotherapy trial design is the presence of non-proportional hazards (NPH) patterns in survival curves. We considered three different NPH patterns caused by delayed treatment effect, cure rate and responder rate of treatment group in this dissertation. These three NPH patterns would violate the proportional hazard model assumption and ignoring any of them in an immunotherapy trial design will result in substantial loss of statistical power.
In this dissertation, four models to deal with NPH patterns are discussed. First, a piecewise proportional hazards model is proposed to incorporate delayed treatment effect into the trial design consideration. …